Dr. Eileen O’Reilly outlines a phase III trial of a targeted therapy for patients with metastatic pancreatic cancer. https://bit.ly/46A8VQD #OncSky #PanCSM
@letswinpc.org
@letswinpc.orgDr. Eileen O’Reilly outlines a phase III trial of a targeted therapy for patients with metastatic pancreatic cancer. https://bit.ly/46A8VQD #OncSky #PanCSM
@pulmonologyadvisor.bsky.socialIn patients with #NonSmallCellLungCancer, active imaging surveillance may improve overall survival following definitive treatment. #PulmSky #OncSky
@alliance-org.bsky.socialTrial Tuesday! Jennifer Ligibel MD of the Dana-Farber and Kathryn Schmitz PhD of @upmchillmancc.bsky.social lead Alliance A222302 studying the feasibility of a telehealth exercise program for cancer patients with the goal of reducing fatigue and disability. https://bit.ly/DEFEND-trial #oncsky #nci
@mdanderson.bsky.socialIt’s likely that more than 1 million patients have benefited from immunotherapy since 2011.
But immunotherapy is not yet curing every patient. The James P. Allison Institute™ is committed to bringing the benefits of immunotherapy to all patients. @pamsharmamdphd.bsky.social #OncSky #EndCancer
@alliance-org.bsky.socialDr. Ugonma Chukwueke of Dana-Farber Cancer Institute leads a new Alliance trial exploring if adding a targeted medicine called vorasidenib to the usual treatment helps people with newly diagnosed IDH mutated grade 3 astrocytoma, a brain cancer. https://bit.ly/Brain2026 #clinicaltrials #oncsky
@mdanderson.bsky.social“He understood that I wasn’t just a leukemia patient. I was a mom,” says Leigh Ann Chiles of our Dr. Guillermo Montalban-Bravo.
She shares how her UT MD Anderson care team not only treated her leukemia, but also helped her safely attend her son’s wedding. #OncSky #EndCancer
@mdanderson.bsky.socialThe most important thing to do after receiving an abnormal Pap test is to seek follow-up care, says our. Dr. Kathleen Schmeler.
Learn more: spr.ly/63324BGp0nE @schmeler.bsky.social #OncSky #EndCancer
@thelancetendo.bsky.social#Endocrine #complications occur in 40–60% of #survivors of #cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism www.thelancet.com/journals/lan...
#OpenAccess
@mdanderson.bsky.socialThyroid nodules are very common, especially as people age.
Dr. Steven Weitzman shares more and what makes UT MD Anderson’s Thyroid Nodule Clinic unique: spr.ly/63320BGTPSO #OncSky #EndCancer
@mdanderson.bsky.socialUT MD Anderson and @springernature.com will co-host "Next Generation Cancer Therapeutics," a conference on the latest research and advances in the development of treatment modalities and the technologies enabling them.
Learn more and register: spr.ly/63324BGr8eO #OncSky #EndCancer
@pulmonologyadvisor.bsky.socialFrom @accpchest.bsky.social 🫁
#Dupilumab was not associated with a significantly increased risk for #lymphoma when compared with other biologics in patients with severe #asthma, though further studies with longer follow-up periods are warranted. #PulmSky #OncSky
@mdanderson.bsky.social“It’s usually not good to have a rare cancer, but it worked out OK for me,” says John Clark III, who received treatment at UT MD Anderson for cancer of unknown primary.
Read his story. #OncSky #EndCancer
@mdanderson.bsky.socialDevices that measure physical activity are effective at encouraging you to stay active and help you monitor your progress as you work to improve your health, Dr. Karen Basen-Engquist explains.
She shares how accurate these devices are and what they can tell you about your health. #OncSky #EndCancer
@mdanderson.bsky.socialBarrett's esophagus happens when corrosive stomach acid seeps back up into your esophagus, causing chronic inflammation.
Given enough time, some of those altered cells can turn cancerous. So, how do you know if you have Barrett’s esophagus? Our Dr. Marta Davila explains. #OncSky #EndCancer
@mdanderson.bsky.social"It’s basic science that led us to cure so many cancer patients," says our Dr. Padmanee Sharma.
She shares how the James P. Allison Institute™ is leading the effort to realize the promise of basic science in medicine and cure more cancer patients. @pamsharmamdphd.bsky.social #OncSky #EndCancer
@alliance-org.bsky.socialDeadline tomorrow! Know an "unsung hero" in cancer clinical trials research? 🩺✨
Nominations are open for the 2026 Richard L. Schilsky CALGB Achievement Award! Help Alliance for Clinical Trials in Oncology honor those making a difference!
🗓️ Deadline: Sept 11 🔗 https://bit.ly/Schilsky26 #oncsky
@mdanderson.bsky.socialWhen Chris Gibson was diagnosed with stage 3 rectal cancer, he wanted to avoid surgery.
After seeking a second opinion at UT MD Anderson, he met with a care team that was able to develop a treatment plan that aligned with his preferences. @rwhuey.bsky.social #OncSky #EndCancer
@springermedicine.comDiscover the current evidence linking #GLP1 receptor agonists and #obesity-related cancers, with emphasis on biologic plausibility, clinical epidemiology, clinical trial evidence, safety signals, and emerging data in active cancer.
@flyingtrilobite.comBonus: there are no AI images in the SciArt Feed!
#academicsky #medsky #ConceptArt #illustration #oncsky #hemesky #neurosky #ArtHistory #humanities 🐡🧪🩺🎨 #nature #wildlife #NoAI #HumanMade #CreateDontScrape